It's common for clinical-stage biotech companies to post net losses, but the market wasn't forgiving of this one's latest.

SALT LAKE CITY, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX) a leading clinical stage TechBio company decoding ...

Recursion reported second-quarter revenue of $19.22 million, beating analyst estimates of $16.23 million, according to ...

Guidance remains unchanged, with management projecting "over $100 million in partnership inflows by the end of 2026" and targeting a cash burn below $390 million in 2026. The company anticipates a ...

Java Island, the heart of Indonesia, is home to two of the most prominent ethnic groups in the country: the Javanese and the ...

In this paper, recursive least-squares linear estimation algorithms are proposed for stochastic systems influenced by uniform quantization, random access protocol (RAP) and deception attacks. With the ...